phenytoin has been researched along with Ataxia of Gait in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Skinner, CG | 1 |
| Chang, AS | 1 |
| Matthews, AS | 1 |
| Reedy, SJ | 1 |
| Morgan, BW | 1 |
| Matsui, M | 1 |
| Tomimoto, H | 1 |
| Sano, K | 1 |
| Hashikawa, K | 1 |
| Fukuyama, H | 1 |
| Shibasaki, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective Randomized Study of Multidose Activated Charcoal in Supratherapeutic Phenytoin Serum Levels[NCT00823264] | 17 participants (Actual) | Interventional | 2008-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
We enrolled patients with elevated phenytoin levels into the study with greater than 30 ug/cc. The treatment arm received multiple doses of activated charcoal and the control arm received no activated charcoal. We obtained serum phenytoin levels every 6 hours for 24 hours then once every 24 hours. The time to reach a subtoxic level was determined in each arm by looking at serum phenytoin levels and documenting when it was below 25 ug/cc. (NCT00823264)
Timeframe: Serum phenytoin levels were obtained every 6 hours for 24 hours then once every 24 hours
| Intervention | hours (Median) |
|---|---|
| Control | 41.1 |
| Multiple Doses of Activated Charcoal | 19.3 |
1 trial available for phenytoin and Ataxia of Gait
| Article | Year |
|---|---|
Randomized controlled study on the use of multiple-dose activated charcoal in patients with supratherapeutic phenytoin levels.
Topics: Adult; Aged; Anticonvulsants; Antidotes; Charcoal; Drug Overdose; Gait Ataxia; Hospitals, Teaching; | 2012 |
1 other study available for phenytoin and Ataxia of Gait
| Article | Year |
|---|---|
Paroxysmal dysarthria and ataxia after midbrain infarction.
Topics: Aged; Anticoagulants; Aspirin; Cerebellum; Diplopia; Dysarthria; Gait Ataxia; Humans; Infarction, Mi | 2004 |